Claudia Del Fante Selected Research

Pre-Eclampsia (Preeclampsia)

2/2006

Daily plasma-exchange for life-threatening class I HELLP syndrome with prevalent pulmonary involvement.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Claudia Del Fante Research Topics

Disease

6	Graft vs Host Disease (Graft-Versus-Host Disease) 06/2021 - 07/2003
6	Wounds and Injuries (Trauma) 02/2018 - 02/2011
4	COVID-19 08/2022 - 01/2020
4	Bronchiolitis Obliterans Syndrome 01/2022 - 06/2010
2	Infections 01/2020 - 11/2014
2	Skin Ulcer 03/2016 - 01/2014
2	Ulcer 10/2013 - 04/2012
1	Critical Illness (Critically Ill) 08/2022
1	Proteinuria 06/2021
1	Renal Insufficiency (Renal Failure) 06/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 12/2020
1	Virus Diseases (Viral Diseases) 01/2020
1	Breakthrough Infections 01/2020
1	Inflammation (Inflammations) 01/2019
1	Autoimmune Diseases (Autoimmune Disease) 02/2018
1	Acute Kidney Injury (Acute Renal Failure) 01/2017
1	Dyskeratosis Congenita (X-Linked Dyskeratosis Congenita) 05/2015
1	Hemophilia A (Haemophilia) 01/2014
1	Pain (Aches) 10/2013
1	Chronic Limb-Threatening Ischemia 10/2013
1	Stomatitis 02/2013
1	Myocardial Infarction 01/2012
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2012
1	Parkinson Disease (Parkinson's Disease) 01/2012
1	Mucositis 09/2011
1	Hemolysis 02/2006
1	Pre-Eclampsia (Preeclampsia) 02/2006
1	HELLP Syndrome 02/2006
1	Thrombotic Microangiopathies 02/2006
1	Immunoglobulin Light-chain Amyloidosis 11/2005

Drug/Important Bio-Agent (IBA)

4	ChitosanIBA 02/2018 - 02/2011
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019 - 02/2011
3	Silver Sulfadiazine (SSD)FDA LinkGeneric 02/2018 - 05/2013
2	Glutamic Acid (Glutamate)FDA Link 02/2018 - 05/2013
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2014 - 05/2013
2	Ophthalmic Solutions (Eye Drops)IBA 02/2013 - 04/2012
1	MicroRNAs (MicroRNA)IBA 01/2022
1	AntibodiesIBA 06/2021
1	Interleukin-6 (Interleukin 6)IBA 06/2021
1	Neutralizing AntibodiesIBA 01/2021
1	C-Reactive ProteinIBA 12/2020
1	Viral DNAIBA 01/2020
1	Peptide Hydrolases (Proteases)FDA Link 01/2019
1	Sulfadiazine (Sulphadiazine)FDA Link 02/2018
1	AntioxidantsIBA 02/2018
1	Oleic Acid (Oleate)IBA 02/2018
1	alpha-Tocopherol FDA Link 02/2018
1	Tocopherols (Tocopherol)IBA 02/2018
1	Cisplatin (Platino)FDA LinkGeneric 01/2017
1	Sericins (Sericin)IBA 03/2016
1	Phosphates (Orthophosphate)IBA 03/2016
1	fludarabineIBA 05/2015
1	Vancomycin FDA LinkGeneric 01/2014
1	PowdersIBA 01/2014
1	platelet-derived growth factor ABIBA 01/2014
1	AlginatesIBA 01/2014
1	Pharmaceutical PreparationsIBA 01/2014
1	HLA Antigens (Human Leukocyte Antigens)IBA 10/2013
1	Lipid NanoparticlesIBA 05/2013
1	Silver CompoundsIBA 05/2013
1	CelluloseIBA 05/2013
1	SolutionsIBA 02/2013
1	UCON 50-HB-5100 (F127)IBA 09/2011
1	carbopol 940 (sodium polyacrylate)IBA 02/2011
1	EnzymesIBA 02/2006
1	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2006

Therapy/Procedure

10	Photopheresis 01/2022 - 07/2003
6	Therapeutics 08/2022 - 01/2012
3	Cell- and Tissue-Based Therapy (Cell Therapy) 02/2018 - 09/2013
2	Drug Therapy (Chemotherapy) 01/2020 - 11/2005
2	Hematopoietic Stem Cell Transplantation 01/2020 - 05/2015
2	Plasma Exchange 01/2014 - 02/2006
1	Artificial Respiration (Mechanical Ventilation) 12/2020
1	Surgical Amputation (Amputations) 10/2013
1	Transplantation 09/2013
1	Stem Cell Transplantation 07/2003